Brief: Recursion Appoints Robert Hershberg As New Chair Of The Board
May 24 (Reuters) - Recursion Pharmaceuticals Inc
RXRX.O :
* RECURSION APPOINTS ROBERT HERSHBERG M.D., PH.D, AS NEW
CHAIR OF
THE BOARD
* RECURSION PHARMACEUTICALS INC: MARTIN CHAVEZ EXITS
Source text for Eikon: ID:nGNX89mgdv
Further company coverage: RXRX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Recursion Pharmaceuticals
See all newsBrief: Tempus And Recursion Extend Existing Data License Agreement And Enter New License Agreement For Recursion’S RNA Foundation Model
Brief: Recursion Pharmaceuticals Enters Amendment To Master Agreement With Tempus On Sept 15, 2026 - SEC Filing
Recursion Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Recursion Pharmaceuticals Q2 revenue misses estimates, cuts 2026 expense outlook
Brief: Recursion Pharmaceuticals Q2 Operating Revenue USD 7.303 Million Vs. IBES Estimate USD 11.9 Million